TY - JOUR AU - Bahary, N; Wang-Gillam, A; Haraldsdottir, S TI - Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer JO - J Clin Oncol VL - 36 PY - 2018 DO - 10.1200/JCO.2018.36.15_suppl.4015 SP - 4015 EP - 4015 N1 - et al. ER -